Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Accunovo Biotechnologies Inc
Profile last edited on: 1/19/24      CAGE: 8FAR0      UEI: DAF9XL6P2BG5

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2018
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

211 Lake Manor Road
Chapel Hill, NC 27516
   (626) 500-9435
   N/A
   www.accunovo.com
Location: Single
Congr. District: 04
County: Orange

Public Profile

Accunovo is bio-science firm developing novel targeted PET imaging probes structured around the combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. Potential end market(s) are suggested to nclude: Diagnostics; herapeutics - Small Molecule; Cancers and other Neoplasms. Products under development include prostate cancer theronostic agents

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$376,447
Phase II Dollars
$0
Total Awarded
$376,447

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $376,447
Project Title: Theranostic NTSR1-targeting Agents for Complementary Management of PSMA-negative Prostate Cancer

Key People / Management

  Lisa Lee -- CEO

  Xiaomei Li

Company News

There are no news available.